跳至主要内容
临床试验/ISRCTN00424386
ISRCTN00424386已完成不适用

Investigating the effectiveness of primary prevention strategies using extensively hydrolysed milk formula and probiotic supplements to prevent allergic disease in high risk infants: pilot factorial randomised controlled trial

Chief Scientist Office (UK)0 个研究点目标入组 36 人开始时间: 2008年2月27日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Infants at high risk of atopy as judged by the mother, father or sibling having an allergic disease (asthma, allergic rhinitis, atopic dermatitis and food allergy)
  • 2. Booked to give birth at the Royal Infirmary, Edinburgh

排除标准

  • 1. Do not give informed consent
  • 2. Multiple pregnancy
  • 3. Delivering prior to 37 weeks gestation

研究者

发起方
Chief Scientist Office (UK)

相似试验